RE: RE: RE: RE: RE: RE: Date ClarificationSharkfood, I was referring to the 2 Oct 2009 announcement of the SPA. The November 2008 announcement was that they were applying for a pivotal trial on head & neck cancers. The reality is that getting approval for bringing a virus into a hospital setting will only happen if there is no effective alternative treatment beyond palliative care. I took the conference call as announcing that they stumbled onto their wedge case. They did not have to continue demonstrating the merits of Reolysin with more phase I & II trials. Face the facts; Oncolytics has treated more than 300 patients in trials with an outbreak. The timeline reflects the challenge. The SPA and Bayesian approach reflects the urgency of getting Reolysin to market.